THEGROUP DC, LLC for ASTELLAS PHARMA US, INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.
Foreign entity interest: Astellas Pharma, Inc., identified on Form LD-1, has interests in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ESTEFANIA RODRIGUEZ | — |
| DARREL THOMPSON | — |
Health Issues HCR
H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.
Foreign entity interest: Astellas Pharma, Inc., identified on Form LD-1, has interests in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ESTEFANIA RODRIGUEZ | — |
| DARREL THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.